Mar 08, 2023 / 04:10PM GMT
Unidentified Analyst -
All right. So it's good to see a stack house on day 3 of TD Cowen 43rd Annual Healthcare Conference. Pleased to be joined by Natera, we got CFO, Mike Brophy; CEO, Steve Chapman.
And so I figured because we have a decent list of questions, we could just dive right in. But maybe before, what do you consider the key highlights of '22? Let's keep it to maybe 1 or 2 each.
Steven Leonard Chapman - Natera, Inc. - CEO, President & Director
Okay. Key highlights '22, well, I mean, look, we continue to have incredible volume and revenue growth in addition to hitting major milestones for Signatera. So muscle invasive bladder coverage, I think continuing to grow the volume in Signatera, getting the CIRCULATE study done and submitted -- allowed us to put ourselves to the position that we're in right now.
Questions and Answers:
Unidentified Analyst -Yes. So we've been covering the stock since in 2017. You were the first salesperson hired, I believe at Natera, is it correct?
Steven Leonard
Trustpilot
